- Home
- Welcome
- Quality
- Customer Service Charter Timeliness Guidelines
- 1. International
- 1.1 International Searching
- 1.1.1 Procedural Outline - PCT International Search
- 1.1.2 Introduction
- 1.1.2.1 Introduction Background
- 1.1.2.2 Introduction International Examination
- 1.1.2.3 General Procedures
- 1.1.2.4 Extent of Search
- 1.1.2.5 Minimum Documentation
- 1.1.2.6 Examination Section Procedures
- 1.1.2.7 Searching Examiner
- 1.1.2.8 Other Considerations
- 1.1.2.9 Copending Applications
- 1.1.3 Search Allocation and Preliminary Classification
- 1.1.4 Unity of Invention
- 1.1.4.1 Unity of Invention Background
- 1.1.4.2 Determining Lack of Unity
- 1.1.4.3 Combinations of Different Categories of Claims
- 1.1.4.4 Markush Practice
- 1.1.4.5 Intermediate and Final Products in Chemical Applications
- 1.1.4.6 Biotechnological Inventions
- 1.1.4.7 Single General Inventive Concept
- 1.1.4.8 A Priori and A Posteriori Lack of Unity
- 1.1.4.9 Issuing the Invitation to Pay Additional Search Fees
- 1.1.4.10 Unsupported Unclear Long
- 1.1.4.11 Payment of Additional Search Fees Under Protest
- 1.1.4.12 Completing the Search Report
- 1.1.4.13 Time for Completing the Search Report
- 1.1.4.14 Reported Decisions
- 1.1.4.15 Other Decisions from the EPO
- 1.1.5 Abstract and Title
- 1.1.6 Subjects to be Excluded from the Search
- 1.1.7 Claim Interpretation, Broad Claims, PCT Article 5 and 6
- 1.1.7.1 Claim Interpretation According to the PCT Guidelines
- 1.1.7.1.1 PCT Guideline References and Flow Chart
- 1.1.7.1.2 Overview of the Hierarchy
- 1.1.7.1.3 Special Meaning, Ordinary Meaning, Everyday Meaning
- 1.1.7.1.4 Closed and Open Definitions and Implications for Interpretation
- 1.1.7.1.5 Implications of the Hierarchy on Searching
- 1.1.7.1.6 PCT GL Appendix Paragraphs 5.20[1] and 5.20[2]
- 1.1.7.1.7 Interpretation of Citations - Inherency
- 1.1.7.2 Broad Claims
- 1.1.7.3 PCT Articles 5 and 6
- 1.1.7.4 Claims Lacking Clarity and Excessive/Multitudinous Claims
- 1.1.7.5 Procedure for Informal Communication with the Applicant
- 1.1.8 Search Strategy
- 1.1.8.1 Introduction
- 1.1.8.2 The Three Person Team (3PT)
- 1.1.8.3 Area of Search
- 1.1.8.4 Search Considerations
- 1.1.9 Basis of the Search
- 1.1.10. Non-Patent Literature
- 1.1.11 Search Procedure
- 1.1.11.1 Overview - Novelty / Inventive Step
- 1.1.11.2 Inventive Step
- 1.1.11.3 Searching Product by Process Claims
- 1.1.11.4 Dates Searched
- 1.1.11.5 Conducting the Search
- 1.1.11.6 Useful Techniques ("piggy back/forward" searching)
- 1.1.11.7 Obtaining Full Copies
- 1.1.11.8 (reserved)
- 1.1.11.9 Considering and Culling the Documents
- 1.1.11.10 Ending the Search
- 1.1.11.11 Categorising the Citations
- 1.1.11.12 Grouping the Claims
- 1.1.12 Search Report and Notification Form Completion
- 1.1.12.1 Background Search Report and Notification Form Completion
- 1.1.12.2 Applicant Details
- 1.1.12.3 General Details
- 1.1.12.4 Fields Searched
- 1.1.12.5 Documents Considered to be Relevant
- 1.1.12.5.1 Selection of Documents Considered to be Relevant
- 1.1.12.5.2 Citation Category
- 1.1.12.5.3 Citation of Prior Art Documents
- 1.1.12.5.4 Citation of URLs
- 1.1.12.5.5 Citation Examples
- 1.1.12.5.6 Citing Patent Documents Retrieved from EPOQUE
- 1.1.12.5.7 Relevant Claim Numbers
- 1.1.12.6 Family Member Identification
- 1.1.12.7 Date of Actual Completion of the Search
- 1.1.12.8 Refund Due
- 1.1.12.9 Contents of Case File at Completion
- 1.1.13 Reissued, Amended or Corrected ISRs and ISOs
- 1.1.14 Priority Document
- 1.1.15 Foreign Patent Search Aids and Documentation
- 1.1.16 Assistance with Foreign Languages
- 1.1.17 Rule 91 Obvious Mistakes in Documents
- 1.1.18. Nucleotide and/or Amino Acid Sequence Listings
- 1.1.18.1 Background Nucleotide and/Or Amino Acid Sequence Listings
- 1.1.18.2 Office Practice
- 1.1.18.3 Summary
- 1.1.19 Annexes
- Annex A - Blank ISR
- Annex B - Completed ISR
- Annex C - Completed ISR
- Annex D - Declaration of Non-Establishment of ISR
- Annex E - Completed Invitation to pay additional fees
- Annex F - Completed ISR with unity observations
- Annex H - Searching Broad Claims
- Annex I - Completed notification of change of abstract
- Annex J - Completed notification of decision concerning request for rectification
- Annex K - The role of the 3 Person Team in Searching
- Annex S - Refund of Search Fees
- Annex U - ISR Quality Checklist
- Annex V - Internet Searching
- Annex W - Obtaining full text from internet
- Annex Z - USPTO kind codes
- Annex AA - Markush Claims
- Annex BB - Article 5/6 Comparisons
- 1.2 International Type Searching
- 1.2.1 Procedural Outline International Type Search Report
- 1.2.2 Introduction - International Type Searching
- 1.2.3 Classification and Search Indication
- 1.2.4 Unity of Invention
- 1.2.5 Subjects to be Excluded from the Search
- 1.2.6 Obscurities, Inconsistencies or Contradictions
- 1.2.7 Abstract and Title
- 1.2.8 Search Report
- 1.2.9 Completing Search Report and Opinion Form
- 1.2.10 Annexes
- 1.3 International Examination
- 1.3.1 Procedural Outline Written Opinion
- 1.3.2 Introduction International Examination
- 1.3.3 The Demand and IPRPII
- 1.3.4 Top-up Search
- 1.3.5 First IPE action
- 1.3.5.1 First IPE Action
- 1.3.5.2 Supplementary International Search Report
- 1.3.5.3 PCT Third Party Observations
- 1.3.6 Response to Opinion
- 1.3.7 IPRPII and Notification
- 1.3.8 Completing ISO, IPEO and IPRPII Forms
- 1.3.8.1 Front Page and Notification Application Details
- 1.3.8.2 Box I Basis of Opinion/Report for ISOs, IPEOs and IPRPs
- 1.3.8.3 Box II Priority
- 1.3.8.4 Box III Non-establishment of Opinion
- 1.3.8.5 Box IV Unity of Invention
- 1.3.8.6 Box V Reasoned Statement Regarding Novelty, Inventive Step & Industrial Applicability
- 1.3.8.7 Box VI Certain Documents Cited
- 1.3.8.8 Box VII Certain Defects
- 1.3.8.9 Box VIII Certain Observations
- 1.3.9 General Considerations
- 1.3.9.1 Article 19 or Article 34(2)(b) Amendments
- 1.3.9.2 Formalities
- 1.3.9.3 General Notes on Form Completion
- 1.3.9.4 Rule 91 Obvious Mistakes in Documents
- 1.3.9.5 Processing withdrawals of PCTs
- 1.3.10 Annexes
- Annex A Sub-Annexes
- Annex AA - Best Practice Example 1
- Annex AB - Best Practice Example 2
- Annex AC - Best Practice Example 3
- Annex AD - Best Practice Example 4
- Annex A - Written Opinion-ISA
- Annex B - Written Opinion-IPEO
- Annex C - Notification of Transmittal of IPERII
- Annex D - IPRPII
- Annex E - IPRPII Clear Novel and Inventive Box V Only
- Annex F - Invitation to Restrict/Pay Additional Fees - Unity
- Annex G - Extension of Time Limit
- Annex H - IPE Quality Checklist
- Annex I - Examples of Inventive Step Objections
- Annex J - Examples of Objections under PCT Articles 5 and 6
- Annex K - Example of PCT Third Party Observations
- Annex L - Blank Written Opinion - ISA
- Annex M - Blank Written Opinion - IPEO
- Annex N - Blank IPRPII
- Annex O - ISO/ISR with Omnibus Claims
- Annex P - PCT Timeline
- 1.4 Fiji Applications
- 1.4.1 Introduction
- 1.4.2 Completion Time and Priority
- 1.4.3 Initial Processing
- 1.4.4 Search Procedure
- 1.4.5 Search Report and Advisory Opinion
- 1.4.6 Further Advisory Opinion
- 1.4.7 Final Processing
- 1.4.8 Annexes
- 1.5 Thai Applications
- 1.5.1 Introduction Thai
- 1.5.2 Completion Time and Priority Thai
- 1.5.3 Initial Processing Thai
- 1.5.4 Search Procedure Thai
- 1.5.5 Search Report Thai
- 1.5.6 Final Processing Thai
- 1.5.7 Annex A - Thai Search Report
- 1.6 WIPO Searches
- 1.6.1 Introduction
- 1.6.2 Completion Time and Priority
- 1.6.3 Initial Processing
- 1.6.4 Search Procedure
- 1.6.5 Search Report
- 1.6.6 Final Processing
- 1.6.7 Annexes
- 1.7 Other Countries
- 1.8 (reserved)
- 1.9 PCT Articles, Regs and Guidelines et al
- 1.10 Miscellaneous
- 2. National
- 2.1 General Approach to Examination
- 2.1.1 Introduction
- 2.1.2 Searching and Use of IPRPI/IPRPIIs and Other Foreign Examination Reports
- 2.1.3 Flexible Approach for Complex Cases
- 2.1.4 Restriction of the Extent of the Report
- 2.1.4A Restriction of the Extent of the Report
- 2.1.5 Inconsistent or Piecemeal Examination
- 2.1.6 Examination and Report Requirements
- 2.1.7 Citations
- 2.1.7.1 Discussion of Citations
- 2.1.7.2 Identifying Citations
- 2.1.7.3 Assertion of Common General Knowledge and Mosaicing
- 2.1.7.4 Citing Many Citations
- 2.1.7.5 Non-Patent Literature
- 2.1.7.6 Providing Copies of Patent Documents
- 2.1.7.7 Unavailable or Untranslatable Citations
- 2.1.8 Furthers
- 2.1.9 Guidelines for Using IPRPI/IPRPIIs and Other Foreign Examination Reports (FERs) in Examination
- 2.1.9.1 Introduction
- 2.1.9.2 FER Retrieval
- 2.1.9.3 FER Validation
- 2.1.9.3.1 Claim Comparison
- 2.1.9.3.2 Not All Claims Previously Searched and/or Examined
- 2.1.9.3.2A Not All Claims Previously Searched and/or Examined
- 2.1.9.3.3 Validation of Novelty and Inventive Step Findings
- 2.1.9.3.4 Law and Practice Differences
- 2.1.9.3.4A Law and Practice Differences
- 2.1.9.3.5 Other Considerations Independent of FER Validity
- 2.1.9.4 FERs and Report Formulation
- 2.1.9.4.1 Objections Based on FER
- 2.1.9.4.2 Identifying Citations, Multiple Citations
- 2.1.9.4.3 New Citations at Further Report
- 2.1.9.5 FERs and Lack of Unity
- 2.1.9.6 FERs and Complex Cases
- Annex A - Open Patent Services (OPS) FER Process
- 2.2 Other Examination Considerations
- 2.2.1 Abbreviations Used in this Volume
- 2.2.2 "Private Applicant" Cases
- 2.2.3 Poor Translations
- 2.2.4 Communication of Report
- 2.2.4.1 Emailing Reports to Applicants or Attorneys, Sending Urgent Reports
- 2.2.4.2 Delayed or Non-Receipt of the Report by the Applicant or Attorney
- 2.2.4.3 Correction of Reports
- 2.2.5 Work Priorities and Case Allocation
- 2.2.6 Responsibility for Furthers, Voluntary Section 104 Amendments
- 2.2.7 Communication with Applicants and Attorneys Outside the Reporting Process and Recording of Case Notes
- 2.2.7.1 Introduction
- 2.2.7.2 Communication with Applicants or Attorneys by Phone
- 2.2.7.3 Communication with Applicants or Attorneys by Email
- 2.2.7.4 Dealing with Applicants or Attorneys in Person
- 2.2.7.5 Recording of Case Notes
- 2.2.8 Summary of IP Reform Changes
- 2.3 Definitions
- 2.3.1 Definitions in the Patents Act
- 2.3.2 Effect of the Acts Interpretation Act
- 2.3.3 Some Examples of Intended Ambits
- 2.3.4 Reckoning of Time
- 2.4 Novelty
- 2.4.1 Introduction
- 2.4.2 Test for Novelty
- 2.4.3 Applying the Test for Novelty
- 2.4.4 Relevant Prior Art
- 2.4.4.1 Prior Art Information
- 2.4.4.1A Prior Art Information
- 2.4.4.2 Meaning of Document
- 2.4.4.3 Publicly Available
- 2.4.4.4 Mosaics and Related Documents
- 2.4.4.5 Resiling from Acknowledged Prior Art
- 2.4.4.6 Exclusions
- 2.4.5 Construing the Citation
- 2.4.6 Level of Disclosure Required
- 2.4.6.1 Practical Utility
- 2.4.6.2 Non-Literal Disclosure
- 2.4.6.3 Clear and Unmistakable Directions
- 2.4.6.4 Mere Paper Anticipations
- 2.4.6.5 Enabling Disclosures
- 2.4.6.6 General Disclosures, Selections
- 2.4.7 All Features Disclosed in Citation
- 2.4.8 Not All Features of Claim Disclosed in Citation
- 2.4.8.1 Introduction
- 2.4.8.2 Features of a Claim prima facie Essential
- 2.4.8.3 Mere Presence in Claim Does Not Ensure Essential
- 2.4.8.4 Materially Affects the Way the Invention Works
- 2.4.8.5 Collocations Kits
- 2.4.8.6 Objects of the Invention, Statements of Prior Art
- 2.4.8.7 Words and Phrases
- 2.4.8.8 Conflicting Statements
- 2.4.8.9 Consideration of Independent and Dependent Claims
- 2.4.9 Doctrine of Mechanical Equivalents
- 2.4.10 All Essential Features Disclosed in Citation
- 2.4.11 "Whole of Contents"
- 2.4.11.1 Introduction
- 2.4.11.2 Basis of the Whole of Contents Objection
- 2.4.11.2A Basis of the "Whole of Contents" Objection
- 2.4.11.3 Priority Date Considerations
- 2.4.11.4 Publication Considerations
- 2.4.11.4A Publication Considerations
- 2.4.11.5 Citation Must be a Single Document
- 2.4.11.6 Citation an International Application under the PCT
- 2.4.11.7 Citation Not OPI
- 2.4.11.8 Citation a Secret Case
- 2.4.11.9 Citation cannot be a Provisional Specification
- 2.4.11.10 Level of Disclosure
- 2.4.12 Novelty - Some Specific Examples
- 2.4.12.1 Chemical Compounds
- 2.4.12.1.1 Construction - Implicit Degree of Purity
- 2.4.12.1.2 Essential Features of Compound Inventions
- 2.4.12.1.3 Enabling Disclosure
- 2.4.12.1.4 Generic Disclosures as Citations
- 2.4.12.1.5 Optical Isomers
- 2.4.12.1.6 Constitutional and Geometric Isomers
- 2.4.12.1.7 Tautomers
- 2.4.12.1.8 Derivatives
- 2.4.12.1.9 Purposive Construction of Compound Claims
- 2.4.12.1.10 Reach-Through Claims
- 2.4.12.2 Range of Variables
- 2.5 Inventive Step
- 2.5.1 Overview
- 2.5.1.1 Introduction
- 2.5.1.2 The Statutory Basis for Inventive Step
- 2.5.1.2A The Statutory Basis for Inventive Step
- 2.5.1.3 Precedent, and the Meaning of Obvious
- 2.5.1.4 Comparison between Novelty and Inventive Step
- 2.5.1.4.1 Prior Art Base
- 2.5.1.4.1A Prior Art Base
- 2.5.1.4.2 Operation of Section 7
- 2.5.1.4.2A Operation of Section 7
- 2.5.1.5 Tests for Inventive Step
- 2.5.1.6 Assessing Inventive Step in Examination
- 2.5.1.6A Assessing Inventive Step in Examination
- 2.5.1.7 Ex Post Facto Analysis
- 2.5.2 Identifying the Relevant Facts
- 2.5.2.1 Common General Knowledge
- 2.5.2.1.1 Introduction
- 2.5.2.1.1A Introduction
- 2.5.2.1.2 What is Common General Knowledge?
- 2.5.2.1.3 Evidence of Common General Knowledge
- 2.5.2.1.4 Acknowledged Prior Art
- 2.5.2.1.5 Common General Knowledge in Australia
- 2.5.2.1.5A Common General Knowledge not Limited to Being in Australia
- 2.5.2.1.6 Patent Specifications as Indicators of Common General Knowledge
- 2.5.2.1.7 Considerations at Further Reports
- 2.5.2.2 Non-Essential Features of the Invention Claimed
- 2.5.2.3 Determining the Problem
- 2.5.2.3.1 Introduction
- 2.5.2.3.1A Introduction
- 2.5.2.3.2 Problem Determined by Reference to Common General Knowledge and Prior Art Information
- 2.5.2.3.3 Claim Does Not Solve the Identified Problem
- 2.5.2.3.4 Amendment of the Problem
- 2.5.2.4 Identifying the Person Skilled in the Art (PSA)
- 2.5.2.4A Identifying the Person Skilled in the Art
- 2.5.2.5 Could the Person Skilled in the Art be Reasonably Expected to have Ascertained, Understood, Regard as Relevant and, Where Applicable, Combined the Prior Art Information?
- 2.5.2.5.1 Ascertained
- 2.5.2.5.2 Understood
- 2.5.2.5.3 Regarded as Relevant
- 2.5.2.5.3.1 Document Discusses the Same, or a Similar, Problem
- 2.5.2.5.3.2 Document Discusses a Different Problem
- 2.5.2.5.3.3 Age of the Document
- 2.5.2.5.3.4 Would the Person Skilled in the Art Have used the Document to Solve the Problem
- 2.5.2.5.4 Does the Document Constitute a Single Source of Information
- 2.5.2.5.5 Could the Person Skilled in the Art Consider it Obvious
- 2.5.2.5.5A Could the Person Skilled in the Art be Reasonably Expected to Have Combined the Prior Art Information to Solve the Problem?
- 2.5.2.5.6 Inventive Step Objections Involving a Combination of Documents
- 2.5.2.5A Prior Art Information
- 2.5.2.6 Evidentiary Requirements
- 2.5.3 Tests for Inventive Step
- 2.5.3.1 Introduction
- 2.5.3.2 Technical Equivalents
- 2.5.3.3 Workshop Improvements
- 2.5.3.3.1 Single Solution to the Problem
- 2.5.3.3.2 Bonus Effect
- 2.5.3.3.3 Several Solutions to the Problem
- 2.5.3.3.4 Selections
- 2.5.3.3.5 Obvious to Try
- 2.5.3.4 Special Inducements, Obvious Selections
- 2.5.3.5 Obvious Combinations of Features of Common General Knowledge
- 2.5.3.6 Invention in Identifying the Real Nature of the Problem
- 2.5.3.7 Invention in the Idea
- 2.5.3.8 Invention in the Purpose
- 2.5.3.9 Sub-Tests of Inventive Step
- 2.5.3.9.1 Prior Art, or Common General Knowledge, Teaches Away From the Solution
- 2.5.3.9.2 Practical Difficulties Overcome
- 2.5.3.9.3 Enabling Disclosures SubTests
- 2.5.3.10 Indicators of Inventive Step
- 2.5.4 Inventive Step - Some Specific Examples
- 2.6 Applicants and Nominated Persons, Patent Requests, Entitlement
- 2.6.1 Applicants and Nominated Persons
- 2.6.2 Patent Requests
- 2.6.2.1 The Request
- 2.6.2.2 Amendment of a Request
- 2.6.2.3 Name of the Applicant and Inventor
- 2.6.2.4 Address for Correspondence
- 2.6.2.5 Address for Service
- 2.6.2.6 Details of Related Applications
- 2.6.3 Entitlement
- 2.6.3.1 Notices of Entitlement
- 2.6.3.2 Identification of the Application
- 2.6.3.3 Who Can Make the Notice
- 2.6.3.4 Statements of Devolution
- 2.6.3.5 Section 15(1)(b) - Service Agreements
- 2.6.4 Changing the Applicant or Nominated Person
- 2.6.4.1 General Considerations
- 2.6.4.2 Section 113 Amendments (Assignment, Agreement or Operation of Law)
- 2.6.4.3 Section 104 Amendments
- Annex A - Examples of Legal Persons
- Annex B - Examples of Organisations of Uncertain Status as Legal Persons
- 2.7 Micro-Organisms and Other Life Forms
- 2.7.1 General Considerations and Definitions
- 2.7.2 Full Written Description of a Life Form
- 2.7.2.1 General Requirements of the Description
- 2.7.2.1A General Requirements of the Description
- 2.7.2.2 Some Specific Requirements for the Written Description of Plant Varieties
- 2.7.2.3 Best Method of Performance of an Invention Involving a Life Form
- 2.7.2.4 The Issue of Repeatability
- 2.7.3 The Budapest Treaty
- 2.7.3.1 Introduction
- 2.7.3.1A Introduction
- 2.7.3.2 Full Description of a Micro-Organism by Satisfying the Deposit Requirements
- 2.7.3.2A Enabling Disclosure of a Micro-Organism by Satisfying the Deposit Requirements
- 2.7.3.3 Inventions Involving the Use
- 2.7.3.4 Deposit Requirements in Modified Examination
- 2.7.3.5 Deposit Requirements Affecting the Priority Date of a Divisional Application
- 2.7.4 The Deposit Requirements
- 2.7.4.1 Types of Deposits Under the Budapest Treaty
- 2.7.4.2 Deposit Requirements Under Section 6
- 2.7.4.3 Deposit Receipt and Notice of Entitlement to Rely on Deposit
- 2.7.5 Amendments to Insert Section 6(c) Information and Extensions of Time Therefor
- 2.7.5.1 Sections 104 and 223 - Insertion of Section 6(c) Information
- 2.7.5.1A Sections 104 and 223 - Insertion of Section 6(c) Information
- 2.7.5.2 Article 34 Amendments Concerning Section 6(c) Information
- 2.7.5.3 Amendment Procedure When a Request for Certification for Release is Pending
- 2.7.5.4 Amendment Procedure When Deposit Requirements Cease to be Satisfied
- 2.7.6 Release of a Sample of Deposit
- 2.7.6.1 Request for Release
- 2.7.6.2 Consideration of Request for Release
- 2.7.6.3 Grant of Certification Authorising Release
- 2.7.6.4 Restrictive Access Provision
- 2.7.7 Deposit Requirements Cease to be Satisfied
- Annexes
- 2.8 Abstracts
- 2.9 Patentability Issues
- 2.9.1 Overview
- 2.9.2 Patentable Subject Matter (Manner of Manufacture)
- 2.9.2.1 Legal Principles
- 2.9.2.2 Reserved
- 2.9.2.3 Alleged Invention
- 2.9.2.4 Fine Arts
- 2.9.2.5 Discoveries, Ideas, Scientific Theories, Schemes and Plans
- 2.9.2.6 Nucleic Acids and Genetic Information
- 2.9.2.7 Computer Implemented Inventions - Schemes and Business Methods
- 2.9.2.8 Printed Matter
- 2.9.2.9 Games and Gaming Machines
- 2.9.2.10 Mathematical Algorithms
- 2.9.2.11 Methods of Testing, Observation and Measurement
- 2.9.2.12 Mere Working Directions
- 2.9.2.13 Treatment of Human Beings
- 2.9.2.14 Micro-Organisms and Other Life Forms
- 2.9.2.15 Agriculture and Horticulture
- 2.9.2.16 Combinations, Collocations, Kits, Packages and Mere Admixtures
- 2.9.2.16.1 Collocations
- 2.9.2.16.2 Kits and Packages
- 2.9.2.16.3 Admixtures
- 2.9.2.16.4 Tips on Claim Construction
- 2.9.2.17 New Uses
- 2.9.2.17.1 New Use of a Known Substance
- 2.9.2.17.2 New Use of an Old Contrivance
- 2.9.2.17.3 Analogous Use
- 2.9.2.18 Ethics and Social Policy
- 2.9.3 Other Issues
- 2.9.3.1 Contrary to Law
- 2.9.3.2 Food or Medicines, Being Mere Admixtures
- 2.9.3.3 General Inconvenience
- 2.9.3.4 Useful (Utility)
- 2.9.3.4A Useful (Utility)
- 2.9.3.4.1A Assessing the Claims for Lack of Usefulness
- 2.9.3.4.1.1A Does the Invention Achieve the Promised Benefit?
- 2.9.3.4.1.2A Specific, Substantial and Credible Use
- 2.9.3.4.2A Consideration of Specific Claim Types
- 2.9.3.4.3A Therapeutic or Pharmacological Use
- 2.9.3.4.4A Contravention of Laws of Nature
- 2.9.3.5 Human Beings and Biological Processes for Their Generation
- 2.9 Annex A - History of Manner of Manufacture
- 2.10 Divisional Applications (Sections 79B and 79C)
- 2.10.1 Application
- 2.10.1A Application
- 2.10.2 Priority Entitlement
- 2.10.2A Priority Entitlement
- 2.10.3 Time Limits for Filing Applications
- 2.10.3A Time Limits for Filing Applications
- 2.10.4 Status of Parent
- 2.10.5 Subject Matter
- 2.10.5A Subject Matter
- 2.10.6 Acceptance
- 2.10.7 Continuation Fees
- 2.10.8 Dividing From a Provisional Application
- 2.10.9 Considering Relative Cases During Examination
- 2.10.10 Amendment of Patent Request - Conversion of Application to a Divisional
- 2.10.10A Amendment of Patent Request - Conversion of Application to a Divisional
- 2.10.11 Case Management of Divisional Applications
- Annex A - Procedural Outline to Divisional Application Examination
- 2.11 Section 40 - Specifications
- 2.11.1 Overview
- 2.11.1A Overview
- 2.11.2 Construction of Specifications
- 2.11.2.1 The Addressee
- 2.11.2.2 Rules of Construction
- 2.11.2.2.1 Construction of Patent Specifications a Question of Law
- 2.11.2.2.2 Words are Given their Plain Meaning
- 2.11.2.2.3 Read the Specification as a Whole
- 2.11.2.2.3A Read the Specification as a Whole
- 2.11.2.2.4 Purposive Construction
- 2.11.2.2.5 Dictionary Principle
- 2.11.2.2.6 Reject the Absurd
- 2.11.2.2.7 The Description Construed as a Technical Document
- 2.11.2.2.8 Errors, Mistakes, Omissions
- 2.11.2.3 Construction of Claims
- 2.11.2.3.1 The Claims are Construed as a Legal Document
- 2.11.2.3.2 A Presumption is Made Against Redundancy
- 2.11.2.3.3 "For Use", "When Used", etc
- 2.11.2.3.3A "For Use", "When Used", etc
- 2.11.2.3.4 "Comprises", "Includes", "Consists of" and "Contains"
- 2.11.2.3.5 Reference Numerals in Claims
- 2.11.2.3.6 Appendancies
- 2.11.2.3.7 Relative Terms
- 2.11.2.3.8 "Substantially" and "About"
- 2.11.2.3.9 Omnibus Claims
- 2.11.2.3.9A Omnibus Claims
- 2.11.2.3.10 Swiss Claims
- 2.11.2.3.11 Product by Process Claims
- 2.11.2.3.12 Parametric Claims
- 2.11.2.4 What is the Invention?
- 2.11.2.4.1 General Considerations
- 2.11.2.4.2 Approach in Lockwood v Doric
- 2.11.2.4.3 Consistory Clause
- 2.11.2.4.3A Consistory Clause
- 2.11.2.4.4 Requirement for Critical Analysis
- 2.11.2.4.5 "Essential Features" of the Invention
- 2.11.2.4A What is the Invention?
- 2.11.3 Full Description, Best Method
- 2.11.3.1 Date for Determining Full Description
- 2.11.3.2 Can the Nature of the Invention be Ascertained?
- 2.11.3.3 Compliance with Subsection 40(2) is a Question of Fact
- 2.11.3.4 Enabling Disclosures
- 2.11.3.5 Effort Required to Perform the Invention
- 2.11.3.6 Different Aspects Claimed in Different Claims
- 2.11.3.7 Inclusion of References
- 2.11.3.8 Trade Marks in Specifications
- 2.11.3.9 Colour Drawings and Photographs
- 2.11.3.10 Claims as Basis of Disclosure
- 2.11.3.11 Contravention of Laws of Nature - e.g. Perpetual Motion Machines
- 2.11.3.12 Relative Terms
- 2.11.3.13 Starting Materials
- 2.11.3.14 Cyclic Inventions
- 2.11.3.15 Biological Inventions and the Budapest Treaty
- 2.11.3.16 Distinction Between Lack of Full Description, Inutility and False Suggestion
- 2.11.3.17 Best Method of Performing the Invention
- 2.11.3.18 At Least One Method Must be Disclosed
- 2.11.3.19 Only One Preferred Embodiment is Required
- 2.11.3A Clear Enough and Complete Enough Disclosure
- 2.11.3.1A Date for Determining Clear Enough and Complete Enough Disclosure
- 2.11.3.3A Compliance with Subsection 40(2) is a Question of Fact
- 2.11.3.4A Principles for Examination
- 2.11.3.4.1A Clarity of Disclosure
- 2.11.3.4.2A Section 40 Enabling Disclosures
- 2.11.3.4.3A Undue Burden
- 2.11.3.7A Inclusion of References
- 2.11.3.8A Trade Marks in Specifications
- 2.11.3.9A Colour Drawings, Graphics and Photographs
- 2.11.3.10A Claims as Basis of Disclosure
- 2.11.3.11A Contravention of Laws of Nature - e.g. Perpetual Motion Machines
- 2.11.3.12A Relative Terms
- 2.11.3.14A Cyclic Inventions
- 2.11.3.15A Biological Inventions and the Budapest Treaty
- 2.11.3.17A Best Method of Performing the Invention
- 2.11.3.18A At Least One Method Must be Disclosed
- 2.11.3.19A Only One Preferred Embodiment is Required
- 2.11.4 Claims Define the Invention
- 2.11.4A Claims Define the Invention
- 2.11.5 Claims are Clear
- 2.11.5.1 Length of Claim
- 2.11.5.2 One Sentence
- 2.11.5.3 Redundant Claims
- 2.11.5.4 Different Combinations of Integers
- 2.11.5.5 Dictionary Definitions
- 2.11.5.6 Cross-References
- 2.11.5.6A Cross-References
- 2.11.5.7 Trade marks in claims
- 2.11.5.7A Trade Marks in Claims
- 2.11.5.8 Disclaimers
- 2.11.5.9 Imprecise Terms - e.g. "About"
- 2.11.5.10 Appendancy Issues
- 2.11.6 Claims are Succinct
- 2.11.7 Claims are Fairly Based
- 2.11.7.1 General Principles
- 2.11.7.2 Sub-Tests for Fair Basis
- 2.11.7.3 Relationship Between the Invention Described and the Invention Claimed
- 2.11.7.4 Only Disclosure is in a Claim
- 2.11.7.5 Alternatives in a Claim
- 2.11.7.6 Claiming by Result
- 2.11.7.7 Reach-Through Claims
- 2.11.7.8 Claims to Alloys
- 2.11.7A Support for the Claims
- 2.11.7.1A Principles for Examination
- 2.11.7.2A Subsection 40(2)(a) 'Clear and Complete Disclosure' v Subsection 40(3) 'Support'
- 2.11.7.3A Inconsistency Between the Invention Disclosed and the Invention Claimed
- 2.11.7.4A Support in View of Proposed Amendments
- 2.11.7.5A Alternatives in a Claim
- 2.11.7.6A Claiming by Result
- 2.11.7.7A Reach-Through Claims
- 2.11.7.8A Claims to Alloys
- 2.11.7.9A Broad or Speculative Claims
- 2.11.7.10A Support Required for Pharmaceutical Inventions and Methods of Treatment
- 2.11.8 Claims Relate to One Invention Only - Lack of Unity
- 2.11.9 Title of the Specification
- 2.11.10 Provisional Specifications
- 2.11.10A Provisional Specifications
- 2.11.11 Complete Applications Associated with Provisional Applications
- 2.11.11A Complete Applications Associated with Provisional Applications
- 2.11.12 Complete Application Treated as a Provisional
- 2.11A Annex A - Examples: Subsections 40(2)(a) and 40(3)
- 2.11A Annex B - Summary of the Clear Enough and Complete Enough Disclosure, Support and Useful (Utility) Provisions
- 2.12 Priority Dates and Filing Dates
- 2.12.1 Priority Dates
- 2.12.1.1 Priority Date of Claims
- 2.12.1.1A Priority Date of Claims
- 2.12.1.2 Priority Date Issues Specific to Associated Applications
- 2.12.1.2A Priority Date Issues Specific to Associated Applications
- 2.12.1.3 Priority Date Issues Specific to Convention Applications
- 2.12.1.3A Priority Date Issues Specific to Convention Applications
- 2.12.1.4 Priority Date Issues Relating to Amended Claims
- 2.12.1.4A Priority Date Issues Relating to Amended Claims
- 2.12.2 Filing Dates
- 2.13 Examination
- 2.13.1 Initial Considerations
- 2.13.2 Applications in a State of Lapse, or Lapsed
- 2.13.2.1 Forms of Lapsing
- 2.13.2.2 Lapsing Prior to Issuing First Report
- 2.13.2.3 Lapsing at Further Report
- 2.13.3 Pending Section 223 Actions
- 2.13.4 Request for Examination
- 2.13.4.1 Request Procedures
- 2.13.4.2 Order of Examination
- 2.13.4.3 Expedited Examination
- 2.13.4.4 Expedited Examination Under the Global Patent Prosecution Highway
- 2.13.4.5 Expedited Examination Under the IP Australia-European Patent Office Patent Prosecution Highway
- 2.13.5 Stringency of Tests During Examination
- 2.13.5.1 Introduction
- 2.13.5.1A Introduction
- 2.13.5.2 Balance of Probabilities
- 2.13.5.2A Balance of Probabilities
- 2.13.5.3 Benefit of Doubt
- 2.13.6 Matters of Form
- 2.13.7 Amendments
- 2.13.7.1 Amendments in Anticipation
- 2.13.7.2 Notice of Incoming Amendments
- 2.13.7.3 Amendments in Partial Response to a Report
- 2.13.7.4 Suggesting Amendments
- 2.13.7.5 Late Filing of Amendments and Responses
- 2.13.8 Review of Classification
- 2.13.9 Searching
- 2.13.10 (reserved)
- 2.13.11 Notices Under Section 27
- 2.13.12 Other Prescribed Matters
- 2.13.13 Examining Cases Subject to a Prohibition Order
- 2.13.13.1 Statutory Basis
- 2.13.13.2 Initial Handling
- 2.13.13.3 Allocation and Handling of Cases
- 2.13.13.4 Searching Prohibited Cases
- 2.13.13.5 Recording Search/Classification Details
- 2.13.14 Copying of Material and Copyright Implications
- 2.13.15 Preliminary Search and Opinion (PSO)
- 2.13.15.1 Introduction
- 2.13.15.2 Applicant Requested PSO
- 2.13.15.3 Amendments
- 2.13.15.4 Search Procedure
- 2.13.15.5 Opinion
- 2.13.15.6 PSO Form Completion
- 2.13.15.7 Response to PSO
- Annexes
- 2.14 Modified Examination
- 2.15 Acceptance of Standard Patent Applications
- 2.15.1 Introduction
- 2.15.2 Misleading Unfair or Derogatory References
- 2.15.3 Processes Operated Outside the Jurisdiction of Australian Law
- 2.15.4 Clear Reports
- 2.15.5 Revocation of Acceptance
- 2.15.6 Time for Acceptance
- 2.15.7 Exending the Time for Acceptance
- 2.15.7.1 Objections Based on "Whole of Contents"
- 2.15.7.2 Objections Based on a Section 27 Notice
- 2.15.7.3 Request for Corrected Translation or Certificate of Verification
- 2.15.7.4 Request for Basic Specification
- 2.15.7.5 Entitlement Disputes During Examination
- 2.15.7.6 Action by a Court or Tribunal
- 2.15.8 Postponement of Acceptance
- 2.16 Petty Patents
- 2.17 Publications
- 2.17.1 Significance of Publication
- 2.17.2 Date of Publication
- 2.17.3 OPI Notified by Error
- 2.17.4 Obtaining OPI Date
- 2.17.5 Published Documents
- 2.17.6 Publication Date of PCT and Foreign Specifications for Citation Purposes
- 2.18 Multiple Applications (Sections 64(2) and 101B)
- 2.18.1 Introduction
- 2.18.2 Practice
- 2.18.3 Examination Reports
- 2.18.4 Requirement that Inventors be the Same
- 2.18.5 Inventions Claimed in a Claim
- 2.18.6 Same Invention
- 2.18.7 Priority Dates
- 2.18.8 Additionals/Divisionals
- 2.18.9 Omnibus Claims
- Annex A - Bar-to-Grant Letter
- 2.19 Patents of Addition (Chapter 7)
- 2.19.1 Applications for Patents of Addition
- 2.19.1.1 Introduction
- 2.19.1.2 Neither Can be an Innovation Patent
- 2.19.1.3 Conditions of Filing
- 2.19.1.4 Patent Must be in Force
- 2.19.1.5 Fees
- 2.19.1.6 Authorisation From Parent Application
- 2.19.1.7 Main Invention Ownership Change
- 2.19.1.8 One Parent Only
- 2.19.1.9 Plural Additional Applications
- 2.19.1.10 Additional to an Additional
- 2.19.1.11 May be Both an Additional and Divisional
- 2.19.2 Examination Procedure
- 2.19.3 Improvement and Modification
- 2.19.4 Amendments Add
- 2.19.5 Timing Provisions
- 2.19.6 Differentiation From the Parent
- 2.19.7 Considering Parent File During Examination
- Annex A - Procedural Outline to Patents of Addition Examination
- 2.20 National Phase Applications
- 2.20.1 Introduction
- 2.20.1.1 Definitions of Terms
- 2.20.1.2 Key Features of the Legislation
- 2.20.1.2A Key Features of the Legislation
- 2.20.1.3 National Phase Preliminaries
- 2.20.1.3A National Phase Preliminaries
- 2.20.1.4 Formality Requirements
- 2.20.1.4A Formalities Check
- 2.20.2 Classification
- 2.20.3 Patent Request and Entitlement
- 2.20.4 Complete Specification in a Foreign Language
- 2.20.4.1 General Considerations
- 2.20.4.2 Translation Supplied by the Applicant
- 2.20.4.3 Translation Supplied by the International Bureau
- 2.20.5 Priority Considerations
- 2.20.5.1 Priority Sources
- 2.20.5.1A Priority Sources
- 2.20.5.2 Obtaining and Considering Priority Documents
- 2.20.6 National Examination Where the ISR is Available
- 2.20.7 National Examination Where the ISR is Missing
- 2.20.8 Use of IPRP
- 2.20.9 According International Filing Dates and Article 25 Applications
- 2.20.10 Amendments and Corrections Prior to Examination
- 2.20.10.1 Determining Whether Amendments Made Under Articles and Rules of the PCT are Considered During Examination
- 2.20.10.1.1 General Provisions
- 2.20.10.1.1A General Provisions
- 2.20.10.1.2 Determining Whether Article 19 and Article 34 Amendments are Considered During Examination
- 2.20.10.1.2A Determining Whether Article 19 and Article 34 Amendments are Considered During Examination
- 2.20.10.1.3 The IASR
- 2.20.10.1.4 The IASF
- 2.20.10.2 Formality Considerations
- 2.20.10.3 Article 19 Amendments
- 2.20.10.4 Article 34 Amendments
- 2.20.10.5 Translation of Amendments
- 2.20.10.6 Amendments Resulting in a Claim to New Matter
- 2.20.10.7 Rule 91 Amendments
- 2.20.10.8 Rule 92bis Amendments
- 2.20.10.9 Corrected Versions of Pamphlet and IPRPII
- 2.20.11 Amendments During Examination
- 2.20.11A Amendments During Examination
- 2.20.12 Chapter 15 Applications (Sections 147 to 153)
- Annexes
- Annex A - Examination of National Phase Applications: Indicators of Special or Different Considerations
- Annex B - Applicant and Inventor Details as Shown on PCT Pamphlet Front Page
- Annex C - Declaration Under Rule 4.17
- Annex D - Verification of Translation
- Annex E - PCT Pamphlet Front Page
- Annex F - Amended Claims Format
- 2.21 Convention Applications
- 2.21.1 Introduction
- 2.21.2 Convention Countries
- 2.21.2.1 Convention Country Listing
- 2.21.2.1A Convention Country Listing
- 2.21.2.2 Basic Applications Filed Before Intergovernmental Organisations
- 2.21.2.3 Convention Country Status Change
- 2.21.2.3A Convention Country Status Change
- 2.21.3 Making Convention Applications
- 2.21.3.1 General Requirements
- 2.21.3.2 Who May Apply
- 2.21.3.3 Basic Applications
- 2.21.3.4 Timing Provisions Convention
- 2.21.3.5 Basic Application Outside 12 Month Convention Period
- 2.21.3.5A Basic Application Outside 12 Month Convention Period
- 2.21.3.6 Basic Applications Having a Parent Application
- 2.21.3.7 Patent Requests and Entitlement
- 2.21.3.8 Basic Specifications
- 2.21.3.9 Converting Convention Applications to Non-Convention, and Vice Versa
- 2.21.3.10 Translation Requirements
- 2.21.3.11 Date of Basic Application
- 2.21.3.12 Convention Priority Dates
- 2.21.3.12A Convention Priority Dates
- 2.22 Re-Examination
- 2.22.1 Introduction
- 2.22.2 Transitional Provisions
- 2.22.3 When Re-Examination Applies
- 2.22.3.1 Between Acceptance and Grant (Applications for Standard Patents)
- 2.22.3.2 Post-Grant (Standard and Innovation Patents)
- 2.22.3.3 Re-examination of Standard Applications and Innovation Patents
- 2.22.4 Re-Examination Consideration
- 2.22.4.1 Scope of the Consideration
- 2.22.4.2 Re-Examination Request
- 2.22.4.3 Material Considered During Re-Examination
- 2.22.4.4 Re-Examination in Light of the Traditional Knowledge Digital Library (TKDL)
- 2.22.5 Re-Examination Report
- 2.22.5.1 Initial Report
- 2.22.5.2 Statement under Section 99 or Section 101H
- 2.22.5.3 Copy of the Statement under Section 99 or Section 101H
- 2.22.5.4 Subsequent Adverse Reports
- 2.22.5.5 Proposed Amendments are Allowable
- 2.22.5.6 Proposed Amendments are not Allowable
- 2.22.5.7 Supervision of Reports
- 2.22.6 Completion of Re-Examination Process
- 2.22.6.1 Completion of Re-Examination in an Opposition Proceeding
- 2.22.6.2 Conclusion of Re-Examination Otherwise
- 2.22.7 Copy of Report on Re-Examination
- 2.22.8 Refusal to Grant a Patent Following Re-examination
- 2.22.9 Revocation of Patent Following Re-examination
- 2.22.9.1 Decision by the Commissioner
- 2.22.9.2 Where Proceedings are Pending
- 2.22.9.3 Appeal by the Patentee
- 2.22.9.4 Appeal by a Third Party
- Annex A - Re-examination Processing
- Annex B - Intention to Re-Examine Letter
- Annex C - Re-Examination Checklist
- 2.23 Amendments
- 2.23.1 Introduction
- 2.23.2 General Provisions - Section 104 Amendments
- 2.23.2.1 Who May Request Amendment
- 2.23.2.2 When Amendment May Be Requested
- 2.23.2.3 What Documents Can Be Amended
- 2.23.2.4 Withdrawal of Amendment Request
- 2.23.2.5 Multiple Requests for Amendment
- 2.23.2.6 National Phase Applications
- 2.23.2.7 Priority in Reporting on Voluntary Requests to Amend
- 2.23.2.8 Unfinalised Proposed Amendments Prior to Examination
- 2.23.3 Formalities
- 2.23.3.1 Form of Request to Amend
- 2.23.3.2 The Document to be Amended
- 2.23.3.3 When Amendments are OPI
- 2.23.3.4 Amendments Arising Out of Decisions or Directions Under Appeal
- 2.23.3.5 Relevant Proceedings Pending
- 2.23.3.6 Consent of Exclusive Licensee or Mortgagee Required
- 2.23.3.7 Requirements in Relation to Providing Reasons for Proposed Amendments
- 2.23.3.8 Form Amendments Should Take
- 2.23.3.9 Amending a Complete Specification Under Section 104 to Comply with a Regulation 3.2A Direction
- 2.23.3.10 Incorporating Amendments into the Specification
- 2.23.3.11 Amendments to Amino Acid and/or Nucleotide Sequences in Electronic Form
- 2.23.4 Fees
- 2.23.4.1 Fees Required for Amendment Requests
- 2.23.4.2 Request to Amend Where Patent/Application is not in Force
- 2.23.5 Granting Leave to Amend/Allowing the Amendments
- 2.23.5.1 Granting Leave to Amend
- 2.23.5.2 Publishing a Notice of the Granting of Leave to Amend
- 2.23.5.3 Allowing Amendments After Granting Leave
- 2.23.5.4 Allowing Amendments Upon Acceptance of a Patent Request and Complete
- 2.23.5.5 Allowing Amendments Immediately Prior to OPI
- 2.23.5.6 Revocation of Leave to Amend
- 2.23.6 Amendments to Complete Specifications
- 2.23.7 Allowability of Amendments to Complete Specifications
- 2.23.7A Allowability of Amendments to Complete Specifications
- 2.23.8 Allowability under Section 102(1)
- 2.23.8A Allowability Under Section 102(1)
- 2.23.9 Allowability Under Section 102(2) etc
- 2.23.9.1 General Comments
- 2.23.9.1A General Comments
- 2.23.9.2 Meaning of fall within the scope of the claims
- 2.23.9.3 Allowability Under Section 102(2)(a)
- 2.23.9.4 Broadening the Scope of the Claims
- 2.23.9.5 Allowability and Omnibus Claims
- 2.23.9.5A Allowability and Omnibus Claims
- 2.23.9.6 Allowability Under Section 102(2)(b)
- 2.23.10 "Clerical Error" and "Obvious Mistake"
- 2.23.10.1 General Comments
- 2.23.10.2 Clerical Error
- 2.23.10.3 Obvious Mistake
- 2.23.10.4 Evidence Required to Prove a Clerical Error or Obvious Mistake
- 2.23.11 Amendments After the Grant of a Patent
- 2.23.12 Other Allowability Issues Concerning Amendments to Complete Specifications
- 2.23.12.1 Amendments Relating to Micro-Organisms
- 2.23.12.2 Amendments Otherwise not Allowable to a Complete Specification
- 2.23.13 Amendment of a Patent Request or of Other Filed Documents
- 2.23.13.1 Amendment of Patent Request
- 2.23.13.2 Amending a Standard Patent Request to an Innovation Patent
- 2.23.13.3 Amending a Non-Convention Patent Request to a Convention Patent Request
- 2.23.13.4 Amending a Convention Patent Request to a Non-Convention Patent Request
- 2.23.13.5 Amending Convention Particulars on a Patent Request
- 2.23.13.6 Adding a Second or Subsequent Basic Application to a Convention
- 2.23.13.7 Amending a Patent Request to a Patent Request for a Patent of Addition
- 2.23.13.8 Amendments to a Provisional Specification
- 2.23.13.8A Amendments to a Provisional Specification
- 2.23.13.9 Amending a Request for Examination
- 2.23.13.10 Amendments to "other filed documents"
- 2.23.14 Amendments During Section 59 Opposition and Section 101M Opposition Proceedings
- 2.23.14.1 General Comments
- 2.23.14.2 Issuing the Invitation
- 2.23.14.3 (reserved)
- 2.23.14.4 Considering the Amendments
- 2.23.14.4.1 Task Priority
- 2.23.14.4.2 Proposed Amendments are Allowable
- 2.23.14.4.3 Proposed Amendments are not Allowable
- 2.23.14.4.4 Further Proposed Amendments
- 2.23.14.4.5 Dealing with Comments
- 2.23.14.5 Amendments as a Result of a Decision
- 2.23.14.6 Opposing Allowance of the Amendments
- 2.23.14.7 Amendments Where Opposition Decision is Being Appealed
- 2.23.15 Opposition to Amendments
- 2.23.16 Amendment of Refused Application
- Annexes
- 2.24 Requesting and Directing Examination, Withdrawal, Lapsing, Extension of Term
- 2.24.1 Requesting and Directing Examination
- 2.24.2 Withdrawal of Applications (Section 141, Regulation 13.1A)
- 2.24.2.1 Withdrawal Opportunity and Effect
- 2.24.2.2 The Request for Withdrawal
- 2.24.2.3 PCT Application
- 2.24.2.4 Stated Disinterest in Proceeding with the Application
- 2.24.2.5 Indexing if Withdrawn After OPI
- 2.24.2.6 Amendments Proposed After Withdrawn
- 2.24.2.7 Related Applications
- 2.24.3 Lapsing of an Application
- 2.24.3.1 Lapsing Under Section 142
- 2.24.3.2 Lapsing for Non-payment of Continuation Fee
- 2.24.3.3 Lapsing Under Section 148
- 2.24.3.4 Lapsing Under Regulations 3.2A(5) and 3.2B(3)
- 2.24.3.5 Lapsing under Regulation 22.2B
- 2.24.4 Extension of Term (Chapter 6, Part 3)
- 2.24.5 Dealing with Lapsed, Withdrawn, Refused, Revoked, Ceased and Expired Cases
- 2.25 The Register of Patents (Chapter 19)
- 2.25.1 The Register
- 2.25.2 Entries in the Register
- 2.25.3 Registration of, and Amendment to, Particulars
- 2.25.4 Correction of the Register
- 2.25.5 Obtaining Information from Register
- 2.26 Employees, Delegations, Administration
- 2.26.1 Restrictions on Patent Office Staff (Sections 182-185)
- 2.26.1.1 Trafficking in Inventions, Trafficking Exemptions
- 2.26.1.2 Provision of Advice
- 2.26.1.3 Helping to Prepare Documents
- 2.26.1.4 Use of Search Material and Information
- 2.26.2 Conflict of Interest
- 2.26.3 Information Obtainable From the Commissioner (Section 194)
- 2.26.4 Delegations (Section 209)
- 2.26.4.1 Statutory Provisions
- 2.26.4.2 Types of Delegations Made by the Commissioner
- 2.26.4.3 Remaking Delegations
- 2.26.4.4 Revoking Delegations
- 2.26.4.5 General Issues Regarding Delegations
- 2.26.4.6 Preparation of Delegations
- 2.26.4.7 Implied Delegations
- 2.26.5 Secret Cases
- 2.27 Payment of Fees (Section 227)
- 2.27.1 Prescribed Fees
- 2.27.2 Fee Payment Basis
- 2.27.3 Fees Not Paid or Requested
- 2.27.4 When Refund or Transfer Not Available
- 2.27.5 Actioning of Requests for Refund or Exemption
- 2.27.6 Mention of Fee Treatment in Examiner's Report
- 2.27.7 Error or Omission in the Patent Office
- 2.27.8 Continuation Fee Timing
- 2.27.9 Exemption From Fees
- 2.27.10 Refund of Certain Fees Regulation 22.7(1)
- 2.28 Transitional and Savings Provisions
- 2.28.1 Introduction
- 2.28.2 Provisions of the Patents Act 1990 (as in Force Immediately Before 15 April 2013)
- 2.28.3 Patent Applications Filed, and Patents Granted, Under the Patents Act 1952
- 2.29 Formalities and Forms
- 2.29.1 Introduction
- 2.29.2 Fitness for Reproduction
- 2.29.3 Numbering of Pages
- 2.29.4 Substitute Pages of Specifications
- 2.29.5 Substitute Documents
- 2.29.6 Units and Terminology
- 2.29.7 Forms
- 2.29.8 Return or Deletion of Filed Documents
- 2.29.9 Requirements for Amino Acids and Nucelotide Sequences on Compact Disc
- 2.29.10 Signature Requirements for Received Documents
- 2.29.11 Drawings, Graphics and Photographs
- 2.29.12 Scandalous Matter
- 2.29.13 Numbering of Claims
- 2.30 Patent Deed
- 2.31 Innovation Patents
- 2.31.1 Features of the System
- 2.31.1.1 Introduction
- 2.31.1.2 Filing
- 2.31.1.3 Formalities Check
- 2.31.1.4 Acceptance and Grant
- 2.31.1.5 Examination
- 2.31.1.6 Certification
- 2.31.1.7 Opposition
- 2.31.1.8 Re-Examination
- 2.31.1.9 Ceasing/Expiring
- 2.31.1.10 Amendments
- 2.31.1.11 Notification by Third Parties
- 2.31.2 Types of Innovation Patent Application
- 2.31.2.1 Section 79B and Section 79C Divisional Applications
- 2.31.2.2 Association with Provisional Applications
- 2.31.2.3 Patents of Addition Innovation
- 2.31.2.4 Convention Applications
- 2.31.2.5 International (PCT) Applications
- 2.31.2.6 Parallel Applications
- 2.31.3 Formalities Check for Innovation Patents
- 2.31.4 Examination
- 2.31.4.1 Introduction
- 2.31.4.2 Period for Examination to be Carried Out
- 2.31.4.3 Grounds of Examination
- 2.31.4.3A Grounds of Examination
- 2.31.4.4 Ground (1): Section 40
- 2.31.4.5 Ground (2): Subsection 18(1A)
- 2.31.4.5.1 Requirements
- 2.31.4.5.2 Patentable Subject Matter (Manner of Manufacture)
- 2.31.4.5.3 Novelty
- 2.31.4.5.4 Innovative Step
- 2.31.4.5.4A Innovative Step
- 2.31.4.6 Ground (3): Subsections 18(2) and (3)
- 2.31.4.7 Amendments
- Annex A - Procedural Outline for Innovation Patent Application Formalities Check by Examiners
- Annex B - Procedural Outline for Examination of an Innovation Patent
- Annex C - Key Features of Innovation Patent System
- Annex D - Innovation Patent Certification Form
- 3. Oppositions, Disputes and Extensions
- 3.1 Role and Powers of the Commissioner in Hearings
- 3.2 Opposition, Disputes and Other Proceedings - Procedural Summaries
- 3.2.1 Section 59 - Opposition to Grant of a Standard Patent
- 3.2.1.1 Commencing the Opposition - Filing a Notice of Opposition
- 3.2.1.2 Filing the Statement of Grounds and Particulars
- 3.2.1.3 Evidence and Evidentiary Periods
- 3.2.1.4 Finalising the Opposition
- 3.2.2 Section 101M - Opposition to an Innovation Patent
- 3.2.2.1 Commencing the Opposition - Filing the Opposition Documents
- 3.2.2.2 Evidence and Evidentiary Periods
- 3.2.2.3 Finalising the Opposition
- 3.2.3 Section 75(1) - Opposition to an Extension of Term of a Pharmaceutical Patent
- 3.2.3.1 Commencing the Opposition - Filing a Notice of Opposition
- 3.2.3.2 Filing the Statement of Grounds and Particulars
- 3.2.3.3 Evidence and Evidentiary Periods
- 3.2.3.4 Finalising the Opposition
- 3.2.4 Section 104(4) - Opposition to a Request to Amend a Filed Document
- 3.2.4.1 Commencing the Opposition - Filing a Notice of Opposition
- 3.2.4.2 Filing the Statement of Grounds and Particulars
- 3.2.4.3 Evidence and Evidentiary Periods
- 3.2.4.4 Finalising the Opposition
- 3.2.5 Section 223(6) - Opposition to an Extension of Time under Subsection 223(2) or 223(2A)
- 3.2.5.1 Commencing the Opposition - Filing a Notice of Opposition
- 3.2.5.2 Filing the Statement of Grounds and Particulars
- 3.2.5.3 Evidence and Evidentiary Periods
- 3.2.5.4 Finalising the Opposition
- 3.2.6 Reg 22.21(4) - Opposition to Grant of a Licence
- 3.2.6.1 Commencing the Opposition - Filing a Notice of Opposition
- 3.2.6.2 Filing the Statement of Grounds and Particulars
- 3.2.6.3 Evidence and Evidentiary Periods
- 3.2.6.4 Finalising the Opposition
- 3.2.7 Sections 17 & 32 - Disputes Between Applicants and Co-Owners
- 3.2.8 Entitlement - Sections 33, 34, 35, 36 and 191A
- 3.3 Directions
- 3.3.1 Directions in Opposition Proceedings
- 3.3.1.1 Direction to Stay an Opposition Pending Another Action
- 3.3.1.2 Further and Better Particulars
- 3.3.1.3 Time for Filing Evidence in a Substantive Opposition
- 3.3.1.4 Time for Filing Evidence in a Procedural Opposition
- 3.3.1.5 General Conduct of Proceedings
- 3.3.1.6 Further Directions
- 3.3.2 Directions that an Application Proceed in Different Name(s) - Section 113
- 3.4 Opposition Documents - Requirements and Amendments
- 3.4.1 The Notice of Opposition
- 3.4.2 The Statement of Grounds and Particulars
- 3.4.3 Amending Opposition Documents
- 3.4.4 Filing Opposition Documents
- 3.5 Evidence
- 3.5.1 Presentation of Evidence
- 3.5.1.1 Written Evidence and Declarations
- 3.5.1.2 Oral Evidence
- 3.5.1.3 Physical Evidence - Special Considerations
- 3.5.2 Admissibility of Evidence
- 3.5.3 Evidence Filed Out of Time
- 3.6 Production of Documents, Summonsing Witnesses
- 3.6.1 Requests for the Commissioner to Exercise Powers under Section 210(a) and (c)
- 3.6.2 Basis for Issuing a Summons
- 3.6.3 Basis for Requiring Production
- 3.6.4 Reasonable Expenses
- 3.6.5 Complying with the Notice or Summons, Reasonable Excuses
- 3.6.6 Sanctions for Non-Compliance
- 3.6.7 Schedule to Requests for Summons or Notice to Produce
- 3.7 Withdrawal and Dismissal of an Opposition
- 3.7.1 Withdrawal of an Opposition
- 3.7.2 Dismissal of an Opposition
- 3.7.2.1 Requests for Dismissal
- 3.7.2.2 Dismissal on the Initiative of the Commissioner
- 3.7.2.3 Reasons for Dismissal
- 3.7.3 Withdrawal of an Opposed Application
- 3.8 Hearings and Decisions
- 3.8.1 Setting Down Hearings
- 3.8.1.1 Setting of Hearing
- 3.8.1.2 Location and Options for Appearing
- 3.8.1.3 Hours of a Hearing
- 3.8.1.4 Hearing Fee
- 3.8.1.5 Who May Appear at a Hearing?
- 3.8.1.6 Relevant Court Actions Pending
- 3.8.2 Hearings Procedure
- 3.8.2.1 Overview of Proceedings
- 3.8.2.2 Adjournment of Hearings
- 3.8.2.3 Contact with Parties Outside of Hearing
- 3.8.2.4 Hearings Involving Confidential Material
- 3.8.2.5 Consultation with Other Hearing Officers
- 3.8.2.6 Hearings and the Police
- 3.8.3 Ex Parte Hearings
- 3.8.4 Natural Justice and Bias
- 3.8.4.1 Rules
- 3.8.4.2 Waiving of Objection of Bias by Standing by until Decision Issued
- 3.8.4.3 Bias as a Result of Contact with Parties Outside of Hearing
- 3.8.4.4 Bias as a Result of Other Proceedings Involving the Same Parties
- 3.8.5 Principles of Conduct
- 3.8.5.1 Lawfulness
- 3.8.5.2 Fairness
- 3.8.5.3 Rationality
- 3.8.5.4 Openness
- 3.8.5.5 Diligence and Efficiency
- 3.8.5.6 Courtesy and Integrity
- 3.8.6 Decisions
- 3.8.6.1 Written Decisions
- 3.8.6.2 Time for Issuing a Decision
- 3.8.6.3 Publication of Decisions
- 3.8.6.4 Rectification of Errors or Omissions in Decisions
- 3.8.6.5 Revocation of Decisions
- 3.8.7 Further Hearings
- 3.8.8 Final Determinations
- 3.8.8.1 Overview of Proceedings
- 3.8.8.2 Applicant Does Not Propose Amendments
- 3.8.8.3 Opponent Withdraws the Opposition
- 3.8.9 Quality
- 3.8.10 Appointment of Hearing Officers and Assistant Hearing Officers, Hearing Officer Standards Panel, Hearing Officer Delegations
- 3.9 Costs
- 3.9.1 Principles in Awarding Costs
- 3.9.2 Scale of Costs, Variation of the Scale
- 3.9.3 Awarding Costs, Taxation
- 3.9.4 Security for Costs
- 3.9.5 Exemplary Situations in Awarding Costs
- 3.10 The Register of Patents
- 3.10.1 What is the Register?
- 3.10.2 Recording Particulars in the Register
- 3.10.2.1 Recording New Particulars in the Register
- 3.10.2.2 Change of Ownership
- 3.10.2.2.1 Assignment
- 3.10.2.2.2 Change of Name
- 3.10.2.2.3 Bankruptcy
- 3.10.2.2.4 Winding Up of Companies
- 3.10.2.2.5 Death of Patentee
- 3.10.2.3 Security Interests
- 3.10.2.4 Licences
- 3.10.2.5 Court Orders
- 3.10.2.6 Equitable Interests
- 3.10.2.7 Effect of Registration or Non-Registration
- 3.10.2.8 Trusts
- 3.10.2.9 False Entries in the Register
- 3.10.3 Amendment of the Register
- 3.11 Extensions of Time and Restoration of the Right of Priority
- 3.11.1 Extensions of Time - Section 223
- 3.11.1.1 Relevant Act
- 3.11.1.2 Subsection 223(1) - Office Error
- 3.11.1.2.1 Extensions under Subsection 223(1) to Gain Acceptance
- Annex A - Section 223(1) Extension of Time for Acceptance File Note
- 3.11.1.3 Subsection 223(2) - Error or Omission and Circumstances Beyond Control
- 3.11.1.3.1 The Law
- 3.11.1.3.2 Subsection 223(2)(a) - Error or Omission
- 3.11.1.3.3 Section 223(2)(b) - Circumstances Beyond Control
- 3.11.1.3.4 Filing a Request under Subsection 223(2)
- 3.11.1.3.5 The Commissioner's Discretion
- 3.11.1.4 Subsection 223(2A) - Despite Due Care
- 3.11.1.5 Common Deficiencies in Requests under Section 223(2) or (2A)
- 3.11.1.6 Advertising an Extension - Subsection 223(4)
- 3.11.1.7 Extension of Time for an Extension of Term
- 3.11.1.8 Grace Period Extensions
- 3.11.1.9 Extension of Time to Gain Acceptance
- 3.11.1.10 Examination Report Delayed or Not Received
- 3.11.1.11 Co-pending Section 104 Application - Budapest Treaty Details
- 3.11.1.12 Payment of Continuation or Renewal Fees Pending a Section 223 Applicaiton
- 3.11.1.13 Person Concerned: Change of Ownership
- 3.11.1.14 Date of a Patent Where an Extension of Time is Granted to Claim Priority
- 3.11.2 Extensions of Time - Reg 5.9
- 3.11.2.1 Requesting an Extension of Time
- 3.11.2.2 Application of the Law
- 3.11.2.3 Justification for the Extension
- 3.11.2.4 Discretionary Matters
- 3.11.2.5 Period of an Extension
- 3.11.2.6 A Hearing in Relation to an Extension
- 3.11.2.7 Parties Involved in Negotiations
- 3.11.2.8 Review of a Decision to Grant or Refuse an Extension
- 3.11.2.9 "Out of Time" Evidence
- 3.11.3 Extensions of Time - Reg 5.10 (as in force immediately before 15 April 2013)
- 3.11.4 Restoration of the Right of Priority under the PCT
- 3.12 Extension of Term of Standard Patents Relating to Pharmaceutical Substances
- 3.12.1 Section 70 Considerations
- 3.12.1.1 Pharmaceutical Substance per se
- 3.12.1.2 Meaning of Pharmaceutical Substance
- 3.12.1.3 Meaning of "when produced by a process that involves the use of recombinant DNA technology"
- 3.12.1.4 Meaning of "mixture or compound of substances"
- 3.12.1.5 Meaning of "in substance disclosed"
- 3.12.1.6 Meaning of "in substance fall within the scope of the claim"
- 3.12.1.7 Included in the Goods
- 3.12.1.8 First Regulatory Approval Date
- 3.12.2 Applying for an Extension of Term
- 3.12.2.1 Documentation Required
- 3.12.2.2 Time for Applying
- 3.12.2.3 Extension of Time to Apply for an Extension of Term
- 3.12.3 Processing an Application for an Extension of Term
- 3.12.3.1 Initial Processing
- 3.12.3.2 Consideration of the Application
- 3.12.3.3 Grant of Application for Extension of Term
- 3.12.3.4 Refusal of Application for Extension of Term
- 3.12.4 Calculating the Length of the Extension of Term
- 3.12.5 Patents of Addition
- 3.12.6 Divisional Applications
- 3.12.7 Opposition to Extension of Term
- 3.12.8 Relevant Court Proceedings Pending
- 3.12.9 Rectification of the Register
- 3.13 Documents not OPI - Orders for Inspection
- 3.13.1 Documents not-OPI by direction of the Commissioner - Regulation 4.3(2)(b)
- 3.13.2 Inspection of non-OPI documents
- 3.14 Appeals, AAT and Judicial Review, Other Court Actions Involving the Commissioner, Section 105 Amendments
- 3.14.1 Appeals to the Federal Court
- 3.14.2 AAT Review
- 3.14.3 Judicial Review
- 3.14.4 Other Court Actions Involving the Commissioner
- 3.14.5 Section 105 Amendments
- 3.15 Computerised Decisions
- 4.1 Searching
- 4.1.1 Objectives of the Search
- 4.1.2 Search Theory
- 4.1.3 Initial Search Considerations
- 4.1.3.1 Construction and the Inventive Concept
- 4.1.3.2 Earlier Search Results
- 4.1.3.3 Additional Searching
- 4.1.3.4 Top-Up Searching
- 4.1.3.5 Preliminary Search
- 4.1.3.6 Applicant and/or Inventor Name Searching
- 4.1.4 Development of the Search Strategy
- 4.1.4.1 Three Person Team (3PT)
- 4.1.4.2 Search Strategy Considerations
- 4.1.4.2.1 Independent Claims
- 4.1.4.2.2 Dependent Claims
- 4.1.4.2.3 Broad Claims
- 4.1.4.2.4 Reserving the Search
- 4.1.4.2.5 Controlled Language
- 4.1.4.3 Search Area
- 4.1.5 Conducting the Search
- 4.1.6 Recording the Search Details
- Annexes
2.9 Annex A - History of Manner of Manufacture
In this topic:
Muntz v Foster (1843) 2 WPC 93
Harwood v Great Northern Railway Co. (1865) 35 LJQB 27
Gadd & Mason v The Mayor etc. of Manchester (1892) 9 RPC 516
British Liquid Air Co. Ltd. v British Oxygen Co. Ltd. (1909) 26 RPC 509
B.A.'s Application (1915) 32 RPC 348
L. & G.'s Application (1941) 58 RPC 21
G.E.C.'s Application (1943) 60 RPC 1
Cementation Co. Ltd.'s Application (1945) 62 RPC 151
Rantzen's Application (1947) 64 RPC 63
Elton and Leda Chemicals Ld.'s Application (1957) RPC 267
Commissioner of Patents v Microcell Ltd (1959) 102 CLR 232
University of Sydney's Application (1970) AOJP 2438
Bernhard Joos v Commissioner of Patents 126 CLR 611; (1972) AOJP 3431
Ranks Hovis McDougall Ltd's Application (1976) AOJP 3915
Wellcome Foundation Limited v The Commissioner of Patents (1980) AOJP 2759
International Business Machines Corporation v Commissioner of Patents (1991) 22 IPR 417
Anaesthetic Supplies Pty Ltd v Rescare Ltd (1994) AIPC 91-076; 28 IPR 383
CCOM Pty Ltd v Jiejing Pty Ltd [1994] FCA 1168
NV Philips Gloeilampenfabrieken v Mirabella International Pty Ltd 32 IPR 449
Grant v Commissioner of Patents [2006] FCAFC 120
Research Affiliates LLC v Commissioner of Patents [2014] FCAFC 150
D’Arcy v Myriad Genetics Inc [2015] HCA 35
Commissioner of Patents v RPL Central Pty Ltd [2015] FCAFC 177
Encompass Corporation Pty Ltd v InfoTrack Pty Ltd [2019] FCAFC 161
The following cases are among the more significant ones in the development of the "traditional principles" underlying the concept of manner of manufacture:
Muntz v Foster (1843) 2 WPC 93
A person who discovers a "hidden and concealed virtue" in something known that enables him to apply the known thing to some useful manufacturing purpose to which it has not been applied before, is entitled to patent the novel application.
In this case, the invention lay in the application of plates made from a particular known alloy for sheathing the bottom of ships, such alloys being found to prevent fouling.
Gadd & Mason v The Mayor etc. of Manchester (1892) 9 RPC 516
The law on new use of old contrivances is set down at page 524 (and adopted by the High Court of Australia in Willmann v Petersen 2 CLR 1 at page 17).
"1. A patent for the mere use of a known contrivance, without any additional ingenuity in overcoming fresh difficulties, is bad and cannot be supported. If the new use involves no ingenuity but is in manner and purpose analogous to the old use, although not quite the same, there is no invention; no manner of new manufacture within the meaning of the Statute of James. 2. On the other hand a patent for a new use of a known contrivance is good and can be supported if the new use involves practical difficulties which the patentee has been first to see and overcome by some ingenuity of his own."
British Liquid Air Co. Ltd. v British Oxygen Co. Ltd. (1909) 26 RPC 509
The principle underlying the doctrine of analogous use was stated at page 532:
"the application of a known device to its ordinary purpose under analogous circumstances is not good subject matter for Letters Patent, because it does not involve invention."
B.A.'s Application (1915) 32 RPC 348
When once a substance is known and its characteristics well defined, the mere use of the substance for purposes not previously known is not patentable. However, a substance cannot be "known" unless its characteristics are well defined; and using a substance because of a property hitherto unknown or unsuspected for a purpose to which it has not formerly been applied would indicate that the chemical was a "known" substance only partially and as far as the new property is concerned, it was unknown.
L. & G.'s Application (1941) 58 RPC 21
The use of a known material in the manufacture of known articles for the reason that it possesses a known property which renders it useful for that purpose is not a manner of new manufacture. Thus, an application for the manufacture of the parts of electricity meters, which are subject to wear, from oxide-coated aluminium, was rejected, since it was known that the coating of aluminium with oxide rendered it resistant to wear.
G.E.C.'s Application (1943) 60 RPC 1
A test for assessing whether a method or process is a manner of manufacture was formulated by Morton J:
"In my view a method or process is a manner of manufacture if it (a) results in the production of some vendible product or (b) improves or restores to its former condition a vendible product or (c) has the effect of preserving from deterioration some vendible product to which it is applied."
Note: It must be kept in mind that Morton's rules are only a guide to assessing whether a method or process is a manner of manufacture. The NRDC case (below) has made it clear that where these rules are used as a guide, the words "vendible" and "product" should be given a broad interpretation. Thus, a product is "vendible" if the question "Is the significance of the product of economic value to the community?" can be answered affirmatively. Moreover, a "product" need not be something in the sense of a tangible article, it may be any artificially created state of affairs.
Commissioner of Patents v Microcell Ltd (1959) 102 CLR 232
The case related to rocket projectors comprising tubes of reinforced synthetic resinous plastic material.
The High Court held that there was:
"in truth nothing but a claim for the use of a known material in the manufacture of known articles for the purpose of which its known properties make that material suitable. A claim for nothing more than that cannot be subject-matter for a patent, and the position cannot be affected either by the fact that nobody thought of doing the thing before, or by the fact that, when somebody did think of doing it, it was found to be a good thing to do".
National Research Development Corporation v Commissioner of Patents (1959) 102 CLR 252; (1961) RPC 134; 1A IPR 63
The concept of a patentable process was considered (CLR at 275):
"The point is that a process, to fall within the limits of patentability which the context of the Statute of Monopolies has supplied, must be one that offers some advantage which is material, in the sense that the process belongs to a useful art as distinct from a fine art ... that its value to the country is in the field of economic endeavour."
and CLR at 269:
"The word "manufacture" finds a place in the present Act, not as a word intended to reduce a question of patentability to a question of verbal interpretation, but simply as the general title found in the Statute of Monopolies for the whole category under which all grants of patents which may be made in accordance with the developed principles of patent law are to be subsumed. It is therefore a mistake, and a mistake likely to lead to an incorrect conclusion, to treat the question whether a given process or product is within the definition as if that question could be restated in the form: "Is this a manner (or kind) of manufacture?" It is a mistake which tends to limit one's thinking by reference to the idea of making tangible goods by hand or by machine, because "manufacture" as a word of everyday speech generally conveys that idea. The right question is: "Is this a proper subject of letters patent according to the principles which have been developed for the application of s. 6 of the Statute of Monopolies?""
Bernhard Joos v Commissioner of Patents 126 CLR 611; (1972) AOJP 3431
Barwick CJ decided that cosmetic processes or methods for improving or changing the appearance of the human body or any part of it which have a commercial application are proper subject matter for the grant of letters patent. The claim, the subject of the decision, was for a process for improving the strength and elasticity of keratinous material, especially human nails and hair, comprising applying thereto a particular composition.
Ranks Hovis McDougall Ltd's Application (1976) AOJP 3915
The question of patenting living organisms was considered. The hearing officer decided that:
no objection can be taken to a claim to a new organism on the ground that it is something living;
any new variants claimed must have improved or altered useful properties and not merely have changed morphological characteristics which have no effect on the working of the organism;
naturally occurring micro-organisms per se are not patentable as they represent a discovery and not an invention; and
a claim to a pure culture of the micro-organism would satisfy the requirements for technical intervention.
Wellcome Foundation Limited v The Commissioner of Patents (1980) AOJP 2759
"The claims in dispute are package claims, i.e. claims to a container with its contents together with a set of written directions. The circumstances in which such package claims will be valid are limited. Novelty in the process for which the package may be used will not be sufficient."
International Business Machines Corporation v Commissioner of Patents (1991) 22 IPR 417
The use of a mathematical formula in a computer to produce an improved curve image was held to be patentable, since the production of the improved curve image is a commercially useful effect in computer graphics. Specifically Burchett J found:
“Although there was nothing new about the mathematics of the invention what was new was the application of the selected mathematical methods to computer, and, in particular, to the production of the desired curve by the computer. This involved steps which were foreign to the normal use of computers and, for that reason, were inventive. A method of producing that by computer, which is novel and inventive, is entitled to the protection of the patent laws.”
Anaesthetic Supplies Pty Ltd v Rescare Ltd
The specification related to a method of treating snoring and/or obstructive sleep apnoea. The court decided that similar principles applied to methods of treatment of the human body for therapeutic purposes as for cosmetic purposes. It held that there was no justification in law or logic to distinguish a process of curative treatment of the human body from that of cosmetic treatment, and that both of these forms of treatment may constitute a manner of manufacture provided they have commercial application. In arriving at its conclusion, the court commented that Parliament, having the opportunity to exclude matters from patentability under the 1990 Act, chose to limit the exclusions to those of sec 18(2).
This decision appeared to reinforce the practice adopted by the Office following the Joos decision that no objection need be taken to methods or processes for the treatment of human beings on that basis alone.
CCOM Pty Ltd v Jiejing Pty Ltd [1994] FCA 1168
The described apparatus in a broad sense consisted of conventional computer equipment including a database, a visual display and a keyboard. Generally, CCOM claimed an interface with a database that contained a data structure of Chinese language characters which encoded strokes by stroke type and in an order in which the strokes are written (if writing by hand). The claim also defined software that presented the strokes on the display for the user. The interface also provided a retrieval program and graphic representation of each character that enabled the user to select the character using the keyboard. The overall outcome was an efficient way of retrieving Chinese characters. Cooper J found that:
“The NRDC Case (102 CLR at 275-277) requires a mode or manner of achieving an end result which is an artificially created state of affairs of utility in the field of economic endeavour. In the present case, a relevant field of economic endeavour is the use of word processing to assemble text in Chinese language characters. The end result achieved is the retrieval of graphic representations of desired characters, for assembly of text. The mode or manner of obtaining this, which provides particular utility in achieving the end result, is the storage of data as to Chinese characters analysed by stroke-type categories, for search including ‘flagging’ (and ‘unflagging’) and selection by reference thereto.”
NV Philips Gloeilampenfabrieken v Mirabella International Pty Ltd 32 IPR 449
The majority of the High Court concluded that "newness" was imported into sec 18(1)(a) to the extent that:
the phrase “manner of manufacture within the meaning of section 6 of the Statute of Monopolies” in s 18(1)(a) should be understood as referring to a process which is a proper subject matter of letters patent according to traditional principles.”
This case sets a threshold requirement that an “alleged” invention must possess the necessary quality of inventiveness, i.e. be an “alleged invention”, on the face of the specification. Simply put, a specification should not “self-admit” a lack of novelty or inventive step. Here, their honours in majority said that if the threshold is not met, then “one need go no further”.
Advanced Building Systems Pty Ltd and Anor v Ramset Fasteners (Aust) Pty Ltd (1998) 152 ALR 604; (1998) AIPC 91-401; 40 IPR 243
The High Court upheld an appeal against a decision taken by the Federal Court, in which that court held that an inventive step had to be present in a "combination" invention in order for it to be patentable under sec 18(1)(a). After commenting that:
"['merit'] was used sometimes in reference to subject-matter, sometimes in reference to novelty. The phrase invites error through imprecision of legal analysis ..."
it concluded:
"In that respect the Full Court [of the Federal Court] was in error in considering under the ground of revocation in sec 100(1)(d) matters that could have arisen under other grounds, namely obviousness and lack of novelty, but which either did not arise or were put to one side."
This decision makes it clear that novelty and inventive step are separate grounds to manner of manufacture, and it is wrong to find that a claim lacks a manner of manufacture because it is not novel or not inventive (aside from the “threshold test” of Philips v Mirabella).
Grant v Commissioner of Patents [2006] FCAFC 120
The requirements for a patentable process were considered by the Full Court at [47]:
“It is necessary that there be some "useful product", some physical phenomenon or effect resulting from the working of a method for it to be properly the subject of letters patent.”
(see also 2.9.2.7 Computer Implemented Inventions – Schemes and Business Methods).
The court also held that:
“Legal advices, schemes, arguments and the like are not a manner of manufacture.”
(see also 2.9.2.5 Discoveries, Ideas, Scientific Theories, Schemes and Plans).
Research Affiliates LLC v Commissioner of Patents [2014] FCAFC 150
The Full Court of the Federal Court dismissed an appeal from a decision of a single judge of the Federal Court finding that a method of generating a weighted share index was not a manner of manufacture. The Full Court found that where it is clear from the specification as a whole that an invention is truly a scheme, an abstract idea or mere intellectual information, which are not patentable themselves, then implementing that invention on a computer is not an artificially created state of affairs that can be held to be patentable.
(see also 2.9.2.7 Computer Implemented Inventions – Schemes and Business Methods)
D’Arcy v Myriad Genetics Inc [2015] HCA 35
The High Court overturned the finding of the Full Court of the Federal Court that isolated nucleic acid sequences coding for mutated or polymorphic forms of the human polypeptide BRCA1 (relating to breast cancer) are patentable. The High Court found that the information stored in the nucleic acid sequences coding for the mutated or polymorphic BRCA1 polypeptide is the same as that contained in the DNA of the person from which the nucleic acid is isolated. This information (which constitutes the substance of the claimed invention) is not ‘made’ by human action and consequently the isolated nucleic acid sequences do not meet the manner of manufacture requirements.
(see also 2.9.2.6 Nucleic Acids and Genetic Information).
Commissioner of Patents v RPL Central Pty Ltd [2015] FCAFC 177
The Full Court of the Federal Court upheld an appeal by the Commissioner of Patents confirming the Commissioner’s decision that an online method for collecting evidence of skills and knowledge to meet a recognised qualification standard (e.g. within the Australian Vocational Education and Training Sector) is not patentable. Extending principles from its decision in Research Affiliates, the Full Court found that the implementation of the method by computer and the internet was insufficient to confer patentability. The Court considered the recent decision of the High Court in D’Arcy v Myriad Genetics Inc [2015] HCA 35, which identified the key requirement to consider the substance of the invention, and found that the present case could be determined under existing principles applicable to computer implemented business methods and did not involve a new class of claim involving a significant extension of the concept of manner of manufacture.
(see also 2.9.2.7 Computer Implemented Inventions – Schemes and Business Methods).
Encompass Corporation Pty Ltd v InfoTrack Pty Ltd [2019] FCAFC 161
An enlarged bench of the Full Court dismissed an appeal by Encompass Corporation in relation to a finding that a method and apparatus for displaying information relating to “entities” (exemplified as, “individuals, corporations, businesses, trusts or any other party involved in a business or other commercial environment”) was not directed to a manner of manufacture. The Full Court reaffirmed the principles developed in Myriad, RPL Central and Research Affiliates. Their Honours made the following observations in deciding that the substance of the claimed invention was nothing more than an abstract idea:
“We observe that the description is largely agnostic as to how the method should be implemented.” [22]
“…the method is really an idea for a computer program, it being left (as we have said) to the user to carry out that idea in an electronic processing device.” [101]
“… the method, as claimed, is no different in principle to the methods claimed in Research Affiliates and RPL Central.” [101]